Anke van den Berg
prof. dr.
I work as a clinical molecular biologist in the department of Pathology. In this function I supervise and implement advanced molecular diagnostic techniques. Within my research line, I focus on the molecular pathogenesis of B-cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are genomic aberrations, genetic susceptibility, and the role of small and long noncoding RNAs. I have several international collaborations and am PI and co-PI in various projects.
Long Non-Coding RNAs As Components Of The MYC Network In B Cell Lymphoma
Joost Kluiver, Melanie Winkle, Mina Tayari, Martijn Terpstra, Gertrud Kortman, Debora de Jong, Jantine Sietzema, Bart Kroesen, Klaas Kok, Anke van den Berg
Long Non-Coding RNAs Are Commonly Deregulated In Hodgkin Lymphoma
Masoumeh Tayari, Klaas Kok, Gertrud Kortman, Jantine Sietzema, Debora de Jang, Martijn Terpstra, Lydia Visser, Arjan Diepstra, Joost Kluiver, Anke Van den Berg
A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc
Wendy Cozen, Dalin Li, Maria Timofeeva, Arjan Diepstra, Dennis Hazelett, Manon Delahaye-Sourdeix, Christopher K. Edlund, Klaus Rostgaard, David J. Van Den Berg, Lude Franke, Karin Eckstrom Smedby, Sally L. Glaser, Harm-Jam Westra, Leslie L. Robison, Thomas M. Mack, Herve Ghesquieres, Arnie E. Hwang, Alexandra Nieters, Silvia de Sanjose, Victoria K. CortessisTracy Lightfoot, Nikolaus Becker, Marc Maynadie, Lenka Foretova, Eve Roman, Yolanda Benavente, Bharat N. Nathwani, Bengt Glimelius, Anthony Staines, Paolo Boffetta, Brian K. Link, L. A. Kiemeney, Stephen M. Ansell, Smita Bhatia, Louise C. Strong, Pilar Galan, Lars Vatten, Thomas M. Habermann, Eric J. Duell, Annette Lake, Rianne Veenstra, Lydia Visser, Kevin Urayama, Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, Graham Byrnes, Mark Lathrop, Hans-Olov Adami, Mads Melbye, James R. Cerhan, Alice Gallagher, G. Malcolm Taylor, Susan L. Slager, Paul Brennan, David V. Conti, Gerhard Coetzee, Kenan Onel, Ruth F. Jarrett, Henrik Hjalgrim, Anke Van Den Berg, James D. McKay
The Role of MicroRNAs in Hodgkin’s Lymphoma
Published in: MicroRNAs in Medicine
Access to document
10.1002/9781118300312.ch26
In this chapter, we summarize the current knowledge on microRNA (miRNA) expression, function and putative clinical value in Hodgkin’s lymphoma (HL). HL is the second most common lymphoma subtype, and mainly affects young adults or elderly. Malignant cells in HL are scarce, usually less than 1%, and these cells are of B-cell origin. As miRNAs are involved in almost all known biological processes, deregulation of miRNAs is thought to play an important role in the pathogenesis of HL. MiRNA expression studies have been performed on HL cell lines,...
Non-coding RNA and tumor cell survival: 9th international symposium on Hodgkin lymphoma (Cologne, Germany)